Latest Secondary Hyperparathyroidism (SHPT) News
Randomized study compared total parathyroidectomy with and without autotransplantation.
Subtotal parathyroidectomy may lower the death risk of patients with secondary hyperparathyroidism and calciphylaxis.
Fracture incidence within a year of transplant was 3 times lower among patients who had surgery from 2009 to 2011 vs 2004 to 2006.
High individual biologic variability in PTH levels are among the factors that may make PTH unreliable as a biomarker of outcomes.
Bone turnover markers increased following unilateral nephrectomy.
Parathyroidectomy may improve leptin regulation and heart rate variability in SHPT patients.
The formulation decreased intact parathyroid hormone levels by at least 10% in 72% of CKD patients with secondary hyperparathyroidism.
The presence of parathyroid nodules suggests worse bone metabolic profiles in patients with severe secondary hyperparathyroidism.
Study implicates male sex and higher preoperative levels of parathyroid hormone and alkaline phosphatase.
Intact parathyroid hormone decreased in dialysis patients taking sucroferric oxyhydroxide but increased in those taking sevelamer carbonate.
Study reveals 6-fold higher risk of SHPT in patients on furosemide vs hydrochlorothiazide.
No new safety concerns emerged during the study.
Serum phosphorus and serum creatinine found to be independent predictors of secondary hyperparathyroidism.
The surgery reduced the risk of death from any cause by 37%, meta-analysis shows.
Over 33 months, the 25-hydroxyvitamin D level of ergocalciferol recipients increased significantly from 15.14 to 37.32 ng/mL.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)